B

PriceBridgeBio Oncology

BBOT

BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.

Historical stock price chart and annual return over the past years

36%

3 months

% Total

BBOT